MUC13 and pancreatic neoplasm: Thus, inhibition of MUC13 via conventional pharmacological agents and/or non-conventional small interfering RNA/microRNA-mediated technologies can selectively suppress pancreatic tumor growth and metastasis via inhibition of glycolytic influx in PanCa cells.